Global Drugs for Asthma and COPD Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03248762

Publication Date:

March 11, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Drugs for Asthma and COPD market size was valued at US$ 44710 million in 2023. With growing demand in downstream market, the Drugs for Asthma and COPD is forecast to a readjusted size of US$ 67390 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Drugs for Asthma and COPD market. Drugs for Asthma and COPD are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drugs for Asthma and COPD. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drugs for Asthma and COPD market.
Drugs used as听treatments for asthma and COPD
The market for drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) is expected to witness substantial growth in the coming years. The increasing prevalence of these respiratory disorders, growing awareness about their diagnosis and management, and advancements in drug therapies are key drivers of market expansion. Bronchodilators and corticosteroids are commonly prescribed medications for asthma and COPD, and the market for these drugs is highly competitive, with several pharmaceutical companies involved in their production and distribution. However, challenges such as high treatment costs, side effects, and the availability of generic alternatives may hinder market growth. Nonetheless, the drugs for asthma and COPD market holds significant opportunities for growth, driven by the rising global burden of these respiratory conditions and the continuous development of novel therapeutic options.
Key Features:
The report on Drugs for Asthma and COPD market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drugs for Asthma and COPD market. It may include historical data, market segmentation by Type (e.g., Inhalable & Nasal Spray, Oral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drugs for Asthma and COPD market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drugs for Asthma and COPD market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drugs for Asthma and COPD industry. This include advancements in Drugs for Asthma and COPD technology, Drugs for Asthma and COPD new entrants, Drugs for Asthma and COPD new investment, and other innovations that are shaping the future of Drugs for Asthma and COPD.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drugs for Asthma and COPD market. It includes factors influencing customer ' purchasing decisions, preferences for Drugs for Asthma and COPD product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drugs for Asthma and COPD market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drugs for Asthma and COPD market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drugs for Asthma and COPD market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drugs for Asthma and COPD industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drugs for Asthma and COPD market.
Market Segmentation:
Drugs for Asthma and COPD market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Inhalable & Nasal Spray
Oral
Others
Segmentation by application
Asthma
COPD
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Asthma and COPD Market Size 2019-2030
2.1.2 Drugs for Asthma and COPD Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drugs for Asthma and COPD Segment by Type
2.2.1 Inhalable & Nasal Spray
2.2.2 Oral
2.2.3 Others
2.3 Drugs for Asthma and COPD Market Size by Type
2.3.1 Drugs for Asthma and COPD Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drugs for Asthma and COPD Market Size Market Share by Type (2019-2024)
2.4 Drugs for Asthma and COPD Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.5 Drugs for Asthma and COPD Market Size by Application
2.5.1 Drugs for Asthma and COPD Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drugs for Asthma and COPD Market Size Market Share by Application (2019-2024)
3 Drugs for Asthma and COPD Market Size by Player
3.1 Drugs for Asthma and COPD Market Size Market Share by Players
3.1.1 Global Drugs for Asthma and COPD Revenue by Players (2019-2024)
3.1.2 Global Drugs for Asthma and COPD Revenue Market Share by Players (2019-2024)
3.2 Global Drugs for Asthma and COPD Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs for Asthma and COPD by Regions
4.1 Drugs for Asthma and COPD Market Size by Regions (2019-2024)
4.2 Americas Drugs for Asthma and COPD Market Size Growth (2019-2024)
4.3 APAC Drugs for Asthma and COPD Market Size Growth (2019-2024)
4.4 Europe Drugs for Asthma and COPD Market Size Growth (2019-2024)
4.5 Middle East & Africa Drugs for Asthma and COPD Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drugs for Asthma and COPD Market Size by Country (2019-2024)
5.2 Americas Drugs for Asthma and COPD Market Size by Type (2019-2024)
5.3 Americas Drugs for Asthma and COPD Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Asthma and COPD Market Size by Region (2019-2024)
6.2 APAC Drugs for Asthma and COPD Market Size by Type (2019-2024)
6.3 APAC Drugs for Asthma and COPD Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Asthma and COPD by Country (2019-2024)
7.2 Europe Drugs for Asthma and COPD Market Size by Type (2019-2024)
7.3 Europe Drugs for Asthma and COPD Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Asthma and COPD by Region (2019-2024)
8.2 Middle East & Africa Drugs for Asthma and COPD Market Size by Type (2019-2024)
8.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs for Asthma and COPD Market Forecast
10.1 Global Drugs for Asthma and COPD Forecast by Regions (2025-2030)
10.1.1 Global Drugs for Asthma and COPD Forecast by Regions (2025-2030)
10.1.2 Americas Drugs for Asthma and COPD Forecast
10.1.3 APAC Drugs for Asthma and COPD Forecast
10.1.4 Europe Drugs for Asthma and COPD Forecast
10.1.5 Middle East & Africa Drugs for Asthma and COPD Forecast
10.2 Americas Drugs for Asthma and COPD Forecast by Country (2025-2030)
10.2.1 United States Drugs for Asthma and COPD Market Forecast
10.2.2 Canada Drugs for Asthma and COPD Market Forecast
10.2.3 Mexico Drugs for Asthma and COPD Market Forecast
10.2.4 Brazil Drugs for Asthma and COPD Market Forecast
10.3 APAC Drugs for Asthma and COPD Forecast by Region (2025-2030)
10.3.1 China Drugs for Asthma and COPD Market Forecast
10.3.2 Japan Drugs for Asthma and COPD Market Forecast
10.3.3 Korea Drugs for Asthma and COPD Market Forecast
10.3.4 Southeast Asia Drugs for Asthma and COPD Market Forecast
10.3.5 India Drugs for Asthma and COPD Market Forecast
10.3.6 Australia Drugs for Asthma and COPD Market Forecast
10.4 Europe Drugs for Asthma and COPD Forecast by Country (2025-2030)
10.4.1 Germany Drugs for Asthma and COPD Market Forecast
10.4.2 France Drugs for Asthma and COPD Market Forecast
10.4.3 UK Drugs for Asthma and COPD Market Forecast
10.4.4 Italy Drugs for Asthma and COPD Market Forecast
10.4.5 Russia Drugs for Asthma and COPD Market Forecast
10.5 Middle East & Africa Drugs for Asthma and COPD Forecast by Region (2025-2030)
10.5.1 Egypt Drugs for Asthma and COPD Market Forecast
10.5.2 South Africa Drugs for Asthma and COPD Market Forecast
10.5.3 Israel Drugs for Asthma and COPD Market Forecast
10.5.4 Turkey Drugs for Asthma and COPD Market Forecast
10.5.5 GCC Countries Drugs for Asthma and COPD Market Forecast
10.6 Global Drugs for Asthma and COPD Forecast by Type (2025-2030)
10.7 Global Drugs for Asthma and COPD Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Drugs for Asthma and COPD Product Offered
11.1.3 GSK Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Drugs for Asthma and COPD Product Offered
11.2.3 AstraZeneca Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Drugs for Asthma and COPD Product Offered
11.3.3 Boehringer Ingelheim Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
11.4.1 Vertex Company Information
11.4.2 Vertex Drugs for Asthma and COPD Product Offered
11.4.3 Vertex Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Vertex Main Business Overview
11.4.5 Vertex Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Drugs for Asthma and COPD Product Offered
11.5.3 Roche Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Drugs for Asthma and COPD Product Offered
11.6.3 Novartis Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Teva
11.7.1 Teva Company Information
11.7.2 Teva Drugs for Asthma and COPD Product Offered
11.7.3 Teva Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Main Business Overview
11.7.5 Teva Latest Developments
11.8 Chiesi
11.8.1 Chiesi Company Information
11.8.2 Chiesi Drugs for Asthma and COPD Product Offered
11.8.3 Chiesi Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Chiesi Main Business Overview
11.8.5 Chiesi Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Drugs for Asthma and COPD Product Offered
11.9.3 Mylan Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Information
11.10.2 Sumitomo Dainippon Drugs for Asthma and COPD Product Offered
11.10.3 Sumitomo Dainippon Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sumitomo Dainippon Main Business Overview
11.10.5 Sumitomo Dainippon Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Drugs for Asthma and COPD Product Offered
11.11.3 Merck Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Beximco
11.12.1 Beximco Company Information
11.12.2 Beximco Drugs for Asthma and COPD Product Offered
11.12.3 Beximco Drugs for Asthma and COPD Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beximco Main Business Overview
11.12.5 Beximco Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂